Geode Capital Management, LLC Enochian Biosciences Inc Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,332,634 shares of ENOB stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,332,634
Previous 1,572,290
48.36%
Holding current value
$10.7 Million
Previous $7.23 Million
48.37%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ENOB
# of Institutions
58Shares Held
19MCall Options Held
41.4KPut Options Held
49.2K-
Vanguard Group Inc Valley Forge, PA5.72MShares$26.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.8 Million0.0% of portfolio
-
State Street Corp Boston, MA2.06MShares$9.5 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL889KShares$4.09 Million0.0% of portfolio
-
Ubs Group Ag764KShares$3.51 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...